Grant: Discovery Horizons
University of Waterloo
$100,000.00
Next Generation of Surgical Microscopes for Real-time Virtual Histopathology
FY 2024-25
Summary
By 2030, new annual cancer diagnoses are expected to increase by 25% in Canada. Surgical excision is an essential part of treatment for most solid tumors. The gold-standard for postoperative cancer margin assessment is the histologic analysis of hematoxylin and eosin (H&E)-stained slides, but this is a complex process that can take from days to weeks before results are returned. Without real-time feedback, it is very difficult to confirm during resection surgery if a negative surgical margin has been achieved. As a result, cancer is left behind in ~20% of initial breast cancer resections, requiring re-excision surgery and/or adjuvant treatments that increase risks, health-care costs, and stress for patients. There is a desperate need for a real-time, non-contact, non-destructive, accurate virtual histology tool for surgical margin assessment in-situ.
Recently, the PI patented a new 2nd-generation optical imaging modality called Photoacoustic Remote Sensing (PARS) that can virtually replicate the gold-standard H&E histology from unstained tissue slides.
Through this grant, the team will develop, test, and validate the final techniques required to build an advanced surgical cancer microscope capable of real-time, non-contact, 3D multilayered H&E-like images directly in-situ. To progress toward this goal, the team will train five PhD students on the following objectives:
Objective 1 (O1; Y1): Build new data acquisition hardware and software to provide a high-resolution image of the cancer margin. Advance novel AI to convert PARS acquisitions to H&E-like images.
O2 (Y1-2): Create and validate PARS multi-photon microscopy to enable safe, deep in-situ imaging.
O3 (Y3-5): Develop an ultrafast camera-based optical absorption technique to enable real-time feedback.
O4 (Y3-5): Devise a novel coherence-gated optical absorption technique to provide real-time multilayered depth-resolved imaging of the cancer margin to guide complete tumour excision in-situ.
Trainees will benefit from participating in cutting edge interdisciplinary research (e.g., engineering, artificial intelligence, image processing, medicine) and by developing new microscopy techniques that, in the long-term, will revolutionize surgical oncology.
Program
Discovery Horizons
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
DH-2023-00371
Name nom
Haji Reza, Parsin
Department département
Systems Design Engineering/Biomedical Engineering - University of Waterloo
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
100000
Program id
DH
Program name en
Discovery Horizons
Program name fr
Horizons de la découverte
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
nan
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1039903
Field of research list names en
Instrumentation in physics
Field of research list names fr
Instrumentation en physique
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Next Generation of Surgical Microscopes for Real-time Virtual Histopathology
Keywords
optics; biomedical optics; cancer imaging; histology; biology; artificial intelligence; image processing software; machine learning; histogram matching
Application summary
By 2030, new annual cancer diagnoses are expected to increase by 25% in Canada. Surgical excision is an essential part of treatment for most solid tumors. The gold-standard for postoperative cancer margin assessment is the histologic analysis of hematoxylin and eosin (H&E)-stained slides, but this is a complex process that can take from days to weeks before results are returned. Without real-time feedback, it is very difficult to confirm during resection surgery if a negative surgical margin has been achieved. As a result, cancer is left behind in ~20% of initial breast cancer resections, requiring re-excision surgery and/or adjuvant treatments that increase risks, health-care costs, and stress for patients. There is a desperate need for a real-time, non-contact, non-destructive, accurate virtual histology tool for surgical margin assessment in-situ.
Recently, the PI patented a new 2nd-generation optical imaging modality called Photoacoustic Remote Sensing (PARS) that can virtually replicate the gold-standard H&E histology from unstained tissue slides.
Through this grant, the team will develop, test, and validate the final techniques required to build an advanced surgical cancer microscope capable of real-time, non-contact, 3D multilayered H&E-like images directly in-situ. To progress toward this goal, the team will train five PhD students on the following objectives:
Objective 1 (O1; Y1): Build new data acquisition hardware and software to provide a high-resolution image of the cancer margin. Advance novel AI to convert PARS acquisitions to H&E-like images.
O2 (Y1-2): Create and validate PARS multi-photon microscopy to enable safe, deep in-situ imaging.
O3 (Y3-5): Develop an ultrafast camera-based optical absorption technique to enable real-time feedback.
O4 (Y3-5): Devise a novel coherence-gated optical absorption technique to provide real-time multilayered depth-resolved imaging of the cancer margin to guide complete tumour excision in-situ.
Trainees will benefit from participating in cutting edge interdisciplinary research (e.g., engineering, artificial intelligence, image processing, medicine) and by developing new microscopy techniques that, in the long-term, will revolutionize surgical oncology.